Two Sigma Investments’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-846,803
| Closed | -$9.48M | – | 2613 |
|
|
2017
Q3 | $9.48M | Sell |
846,803
-85,872
| -9% | -$962K | 0.03% | 485 |
|
|
2017
Q2 | $10.3M | Buy |
932,675
+698,347
| +298% | +$7.68M | 0.04% | 456 |
|
|
2017
Q1 | $2.3M | Buy |
234,328
+50,150
| +27% | +$491K | 0.01% | 1093 |
|
|
2016
Q4 | $1.99M | Sell |
184,178
-10,766
| -6% | -$116K | 0.01% | 1162 |
|
|
2016
Q3 | $2M | Buy |
194,944
+116,755
| +149% | +$1.2M | 0.01% | 1031 |
|
|
2016
Q2 | $1.02M | Buy |
78,189
+56,370
| +258% | +$736K | ﹤0.01% | 1311 |
|
|
2016
Q1 | $240K | Sell |
21,819
-111,756
| -84% | -$1.23M | ﹤0.01% | 1861 |
|
|
2015
Q4 | $1.23M | Buy |
133,575
+106,275
| +389% | +$978K | 0.01% | 1152 |
|
|
2015
Q3 | $189K | Sell |
27,300
-128,438
| -82% | -$889K | ﹤0.01% | 1498 |
|
|
2015
Q2 | $1.53M | Sell |
155,738
-66,527
| -30% | -$653K | 0.01% | 1201 |
|
|
2015
Q1 | $1.97M | Buy |
222,265
+32,149
| +17% | +$285K | 0.01% | 1085 |
|
|
2014
Q4 | $1.67M | Sell |
190,116
-121,557
| -39% | -$1.06M | 0.01% | 1104 |
|
|
2014
Q3 | $2.15M | Buy |
311,673
+216,231
| +227% | +$1.49M | 0.01% | 848 |
|
|
2014
Q2 | $502K | Buy |
95,442
+33,093
| +53% | +$174K | ﹤0.01% | 1605 |
|
|
2014
Q1 | $284K | Sell |
62,349
-64,309
| -51% | -$293K | ﹤0.01% | 1695 |
|
|
2013
Q4 | $638K | Buy |
126,658
+49,858
| +65% | +$251K | ﹤0.01% | 1561 |
|
|
2013
Q3 | $389K | Sell |
76,800
-28,638
| -27% | -$145K | ﹤0.01% | 1395 |
|
|
2013
Q2 | $523K | Buy |
+105,438
| New | +$523K | ﹤0.01% | 1386 |
|